NVX-CoV2373 is engineered from the genetic sequence of SARS-CoV-2 using the Company’s recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein.
The US FDA’s vaccine advisory panel voted unanimously to recommend the agency approve the emergency use of Moderna’s COVID-19 vaccine in children aged 6 to 17.
The trial included 1678 children who received a third dose of the 3 µg formulation at least 2 months after the second dose of a 2-dose series at a time when Omicron was the predominant variant.
A single booster dose of the Pfizer COVID-19 vaccine can be given to 5- to 11-year-olds.
No safety signal is observed between COVID-19 vaccines and immune-mediated neurological events, but infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with increased risks for Bell palsy, encephalomyelitis, and Guillain-Barré syndrome.
Suzette Oyeku, MD, MPH, speaks to us about the existing disparities in childhood COVID-19 vaccine access and the role of providers in ensuring vaccine uptake among pediatric populations.
Receipt of COVID-19 vaccination is associated with declines in psychological distress reported by US adults.
Younger mothers, both Black and White, are the least open to vaccinating their children against COVID-19.
Maternal vaccination with the Pfizer-BioNTech COVID-19 vaccine in pregnancy is safe and not associated with detrimental outcomes to the offspring.
Three social factors, conspiracy mentality, prosociality, and authoritarianism, were examined by researchers to determine the longitudinal relations between individual willingness to undergo vaccination against COVID-19.
